We are what we eat: Jim Mellon exclusive
Longevity, biotech, investment, sustainability and ethics: Jim Mellon’s new book, MOO’S LAW, addresses the opportunities and challenges of our need…
4 years ago
Partner Content
Busting some of the common myths about investing in private equity
Helen Steers, Partner at Pantheon and Manager of Pantheon International Plc (PIP), addresses some of the common myths surrounding private…
4 years ago
Longevity market blockbuster? Senolytic drug development is attracting investor interest
By killing so-called zombie cells which accelerate the ageing process, drugs called senolytics promise to keep us younger and fitter…
4 years ago
Longevity Market Watch: The Longevity doctor will see you now
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
4 years ago
Longevity Market Watch
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
4 years ago
Longevity Week Review
Michael Corcoran and James Lawford Davies of Hill Dickinson discuss the firm's participation in Longevity Week and the longevity sector…
4 years ago
Longevity Market Watch
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
4 years ago
Longevity Market Watch
In this weekly update, Longevity.Technology Editor-in-Chief Phil Newman keeps us up to date with all the latest developments in longevity.
4 years ago
Longevity Market Watch
In this weekly update, longevity.technology Editor in Chief Phil Newman keeps us up to date with all the latest development…
4 years ago
COVID-19: our performance, positioning and trading activity
It is too early to be overly confident, but we are gradually building confidence in the outlook for the market,…
5 years ago